A Seroquel lawsuit that was set to be the first of thousands of cases nationwide to go to trial, was dismissed yesterday by a Delaware state court judge who excluded testimony from the medical expert necessary for the plaintiff to establish that she developed diabetes from AstraZeneca’s Seroquel.
The Delaware lawsuit was filed on behalf of Nina Scaife, from Kansas, who allegedly developed diabetes after taking Seroquel off-label for treatment of insomnia. Her claim was one of more than 9,000 similar lawsuits filed in federal and state courts throughout the United States, and was scheduled for trial to begin on June 29, 2009.
Although it is widely acknowledged that side effects of Seroquel may increase the risk of weight gain and diabetes, each individual plaintiff still has the burden of establishing a connection between Seroquel and their diabetes diagnosis.
Excerpted from AboutLawsuits.com.
